Nutrition for the Preterm Infant: Impact on Growth, Development, and Intestinal Health

Sponsored by the Academy for Continued Healthcare Learning.

This activity is supported in part by an independent education grant from Abbott Nutrition.

Scroll to the Bottom of this Information to Begin this Course

Release date: April 28, 2017

Valid through: April 28, 2018

Specialty: Pediatrics, Nutrition, Neonatalogist

Topic: Nutrition for the Preterm Infant

Media: Internet

Estimated Time to Complete Activity: 30 minutes

Target Audience

The CME activity is intended for pediatricians, pediatric nurse practitioners, nurses and others with an interest in infant nutrition.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Identify nutritional differences among preterm, preterm-discharge, and standard-term formulas and formulate strategies to transition preterm infants to term formulas, when appropriate.
  • Illustrate how the gut microbiome is altered in preterm infants and how it can be partially optimized through diet to minimize disease.
  • Examine nutritional differences between plain human milk, enriched human milk, fortified human milk (FHM) and the various available commercial preterm formulas, including the role of LCPUFA supplementation on growth and development of both preterm and full-term infants.
  • Discuss strategies to educate parents and guardians regarding infant nutrition.

Credit Available

  • Physicians — maximum of 0.5 AMA PRA Category 1 Credits
  • Nurses — 0.10 contact hour(s) for IACET

All other healthcare professionals completing this course will be issued a statement of participation.

Faculty

Sharon Groh-Wargo, PhD, RD, LD

Professor of Pediatrics and Nutrition
Case Western Reserve University School of Medicine
Cleveland, Ohio

Accreditation Statement

Physicians

The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Nurses

The Academy for Continued Healthcare Learning has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET). ACHL is authorized by IACET to offer 0.10 CEU for this program. IACET CEUs are accepted by the American Nurses Association. Contact your licensing agency for details. 0.10 CEU = 60 minutes

Credit Designation

Physicians

Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

ACHL is authorized by IACET to offer 0.10 CEU for this program. IACET CEUs are accepted by the American Nurses Association. Contact your licensing agency for details. 0.10 CEU = 60 minutes

Disclosures of Conflicts of Interest

The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.

Sharon Groh-Wargo, PhD, RD, LD
  • Speakers Bureau/Honorarium recipient: Abbott Nutrition
  • Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

Instructions for Participation and Credit

There are no fees for participating and receiving credit for this activity. During the accredited period, participants must read the learning objectives and faculty disclosures; study the educational activity; and complete the post-test and the evaluation form. Passing grade is 75% and you are limited to 5 attempts. If you pass the post-test and complete the evaluation, your certificate will be available immediately for download in PDF format.

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.

Disclosure of Unlabeled Use

This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Clinicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support, as well as the ACPE Accreditation Standards for Continuing Pharmacy Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.